Corroon James M, Mischley Laurie K, Sexton Michelle
Center for Medical Cannabis Education, Del Mar, CA.
Bastyr University Research Institute, Kenmore, WA.
J Pain Res. 2017 May 2;10:989-998. doi: 10.2147/JPR.S134330. eCollection 2017.
The use of medical cannabis is increasing, most commonly for pain, anxiety and depression. Emerging data suggest that use and abuse of prescription drugs may be decreasing in states where medical cannabis is legal. The aim of this study was to survey cannabis users to determine whether they had intentionally substituted cannabis for prescription drugs.
A total of 2,774 individuals were a self-selected convenience sample who reported having used cannabis at least once in the previous 90 days. Subjects were surveyed via an online anonymous questionnaire on cannabis substitution effects. Participants were recruited through social media and cannabis dispensaries in Washington State.
A total of 1,248 (46%) respondents reported using cannabis as a substitute for prescription drugs. The most common classes of drugs substituted were narcotics/opioids (35.8%), anxiolytics/benzodiazepines (13.6%) and antidepressants (12.7%). A total of 2,473 substitutions were reported or approximately two drug substitutions per affirmative respondent. The odds of reporting substituting were 4.59 (95% confidence interval [CI], 3.87-5.43) greater among medical cannabis users compared with non-medical users and 1.66 (95% CI, 1.27-2.16) greater among those reporting use for managing the comorbidities of pain, anxiety and depression. A slightly higher percentage of those who reported substituting resided in states where medical cannabis was legal at the time of the survey (47% vs. 45%, =0.58), but this difference was not statistically significant.
These patient-reported outcomes support prior research that individuals are using cannabis as a substitute for prescription drugs, particularly, narcotics/opioids, and independent of whether they identify themselves as medical or non-medical users. This is especially true if they suffer from pain, anxiety and depression. Additionally, this study suggests that state laws allowing access to, and use of, medical cannabis may not be influencing individual decision-making in this area.
医用大麻的使用正在增加,最常见的用途是缓解疼痛、焦虑和抑郁。新出现的数据表明,在医用大麻合法的州,处方药的使用和滥用情况可能正在减少。本研究的目的是对大麻使用者进行调查,以确定他们是否有意用大麻替代处方药。
共有2774人是自我选择的便利样本,他们报告在过去90天内至少使用过一次大麻。通过在线匿名问卷对受试者进行大麻替代效应调查。参与者通过华盛顿州的社交媒体和大麻药房招募。
共有1248名(46%)受访者报告使用大麻替代处方药。最常被替代的药物类别是麻醉药品/阿片类药物(35.8%)、抗焦虑药/苯二氮䓬类药物(13.6%)和抗抑郁药(12.7%)。总共报告了2473次替代情况,即每位肯定回答的受访者约有两次药物替代。与非医用大麻使用者相比,医用大麻使用者报告替代的几率高4.59(95%置信区间[CI],3.87 - 5.43);在报告使用大麻来管理疼痛、焦虑和抑郁等合并症的人群中,这一几率高1.66(95%CI,1.27 - 2.16)。报告进行替代的人群中,居住在调查时医用大麻合法州的比例略高(47%对45%,P = 0.58),但这一差异无统计学意义。
这些患者报告的结果支持了先前的研究,即人们正在用大麻替代处方药,特别是麻醉药品/阿片类药物,且无论他们将自己视为医用还是非医用使用者。如果他们患有疼痛、焦虑和抑郁,情况尤其如此。此外,本研究表明,允许获取和使用医用大麻的州法律可能并未影响这一领域的个人决策。